2022 X Asian congress on endometriosis Moscow, october 6–8, 2022. Abstracts of reports ·doi:10.17116/rosakush20222205211
2018 Advisory Board Resolution on the subject: 'Possibilities of personalized hormone-based therapies for endometriosis using dydrogesterone / Approval of the protocol of an Observational Open-Label Multicenter Study of Real Clinical Practice to Evaluate the Effects of Hormonal therapy with Oral Dydrogesterone for Treatment of Confirmed Endometriosis (the ORCHIDEA study)' ·doi:10.17116/repro20182405141